Artificial intelligence and machine learning applications in dialysis: Current applications, challenges, and future directions

Artificial intelligence (AI) and machine learning (ML) applications have emerged as transformative technologies in nephrology, particularly in dialysis care. The availability of multimodal datasets including electronic health records, hemodialysis machine data, laboratory values, and imaging has enabled the development of sophisticated prognostic, diagnostic, and treatment support tools. This comprehensive review narratively examines current AI/ML applications in dialysis, evaluates their clinical performance, and identifies future research directions. We conducted a comprehensive literature search of PubMed, Web of Science, and other major databases from 2020 to 2025, focusing on peer-reviewed studies that employed AI/ML techniques in dialysis care. Studies were categorised by application domain and analysed for methodology, performance metrics, and clinical implications. Our analysis identified five major application domains: (1) prediction and prognosis, including intradialytic hypotension (IDH) prediction with AUROC values ranging 0.89-0.95, mortality prediction achieving C-indices up to 0.83, and hospitalisation risk assessment; (2) early detection of chronic kidney disease (CKD) progression and dialysis risk; (3) clinical decision support for anaemia management and treatment optimisation; (4) vascular access monitoring with AI-driven image analysis achieving AUROC ≈ 0.96; and (5) natural language processing (NLP) applications for symptom detection. Federated learning (FL) approaches are emerging to enable multi-centre collaboration while preserving data privacy. AI/ML technologies demonstrate significant promise in enhancing dialysis care through improved prediction accuracy, personalised treatment approaches, and clinical decision support. However, widespread clinical adoption remains limited due to challenges including data privacy concerns, model interpretability issues, regulatory complexity, and the need for diverse, representative datasets.

Authors

Institutions

Publication Details

Journal
Clinica Chimica Acta
Published
2026-02-15
DOI
https://doi.org/10.1016/j.cca.2026.120908
Primary Topic
Dialysis and Renal Disease Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Artificial intelligence and machine learning applications in dialysis: Current applications, challenges, and future directions

Aanuoluwapo Clement David-Olawade, David B. Olawade, Muyiwa Ademola Ogunbona, John Oluwatosin Alabi et al.
Clinica Chimica Acta
Dialysis and Renal Disease Management
article

Artificial intelligence and machine learning applications in dialysis: Current applications, challenges, and future directions

Aanuoluwapo Clement David-Olawade, David B. Olawade, Muyiwa Ademola Ogunbona, John Oluwatosin Alabi, Olabanke Florence Olawuyi, Babajide David Makanjuola
article en

Abstract

Artificial intelligence (AI) and machine learning (ML) applications have emerged as transformative technologies in nephrology, particularly in dialysis care. The availability of multimodal datasets including electronic health records, hemodialysis machine data, laboratory values, and imaging has enabled the development of sophisticated prognostic, diagnostic, and treatment support tools. This comprehensive review narratively examines current AI/ML applications in dialysis, evaluates their clinical performance, and identifies future research directions. We conducted a comprehensive literature search of PubMed, Web of Science, and other major databases from 2020 to 2025, focusing on peer-reviewed studies that employed AI/ML techniques in dialysis care. Studies were categorised by application domain and analysed for methodology, performance metrics, and clinical implications. Our analysis identified five major application domains: (1) prediction and prognosis, including intradialytic hypotension (IDH) prediction with AUROC values ranging 0.89-0.95, mortality prediction achieving C-indices up to 0.83, and hospitalisation risk assessment; (2) early detection of chronic kidney disease (CKD) progression and dialysis risk; (3) clinical decision support for anaemia management and treatment optimisation; (4) vascular access monitoring with AI-driven image analysis achieving AUROC ≈ 0.96; and (5) natural language processing (NLP) applications for symptom detection. Federated learning (FL) approaches are emerging to enable multi-centre collaboration while preserving data privacy. AI/ML technologies demonstrate significant promise in enhancing dialysis care through improved prediction accuracy, personalised treatment approaches, and clinical decision support. However, widespread clinical adoption remains limited due to challenges including data privacy concerns, model interpretability issues, regulatory complexity, and the need for diverse, representative datasets.

Clinica Chimica ActaVol. 586
University of East London (GB), University of Sussex (GB), University of Ibadan (NG), Glenfield Hospital (GB), University Hospitals of Leicester NHS Trust (GB), University of Calabar (NG), Sheffield Hallam University (GB)
Openalex Percentile: Top 60%
Dialysis and Renal Disease Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.